Found: 7
Select item for more details and to access through your institution.
A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 4, p. 954, doi. 10.1007/s10637-015-0239-1
- By:
- Publication type:
- Article
Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes.
- Published in:
- 1996
- By:
- Publication type:
- journal article
<sup>18</sup>F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12).
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 635, doi. 10.1007/s40487-021-00173-1
- By:
- Publication type:
- Article
Second-line Chemotherapy with Biweekly Paclitaxel after Failure of Fluoropyrimidine-based Treatment in Patients with Advanced or Recurrent Gastric Cancer: a Report from the Gastrointestinal Oncology Group of the Tokyo Cooperative Oncology Group, TCOG ...
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 11, p. 713
- By:
- Publication type:
- Article
Regulation of survival and death of mesangial cells by extracellular matrix.
- Published in:
- Kidney International, 1998, v. 54, n. 4, p. 1188, doi. 10.1046/j.1523-1755.1998.00116.x
- By:
- Publication type:
- Article
Pancreas Histology and a Longitudinal Study of Insulin Secretion in a Japanese Patient With Latent Autoimmune Diabetes in Adults.
- Published in:
- Diabetes Care, 2008, v. 31, n. 10, p. e69, doi. 10.2337/dc08-1082
- By:
- Publication type:
- Article
O<sup>6</sup>-Methylguanine-DNA Methyltransferase (MGMT) as a Determinant of Resistance to Camptothecin Derivatives.
- Published in:
- Cancer Science, 2002, v. 93, n. 1, p. 93, doi. 10.1111/j.1349-7006.2002.tb01205.x
- By:
- Publication type:
- Article